Google DeepMind, along with Meta and AI drug discovery startup Isomorphic Labs, has announced a significant investment of $300 million into Biohub, a nonprofit biomedical research organization founded by Mark Zuckerberg and Priscilla Chan. This funding is part of a larger $1.8 billion initiative aimed at developing AI datasets that could enhance research capabilities in the biomedical field.
The collaboration seeks to leverage advanced AI technologies to enable researchers to ask complex questions, predict outcomes, and streamline the drug discovery process. By building comprehensive datasets, the initiative aims to tackle some of the most pressing challenges in healthcare and medicine.
This strategic investment underscores the growing intersection of AI and healthcare, as tech giants recognize the potential of artificial intelligence to transform medical research and improve patient outcomes.
Compiled automatically by the Tech AI Newsdesk from public AI-news sources and summarised in our own words.
